In patients with IBD, increased levels of intestinal expression of TLR4 and other proinflammatory molecules such as cyclooxygenase-2 (COX-2) and interleukin (IL)-8 have been observed [24], [25]. This evidence concerns the gene PTGS2 and inflammatory bowel disease.